Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
For reconstitution, add sterile, distilled water to achieve a final antibody concentration of 1 mg/mL. Gently shake to solubilize the protein completely. Do not vortex. Reconstituted products should be stored at -80 °.
This antibody can also be cross referenced by the term Tqb2858.
Programmed Cell Death Ligand 1 (PD-L1), encoded by the CD274 gene, is a trans-membrane protein that serves as a co-inhibitory factor in the immune response. It is widely expressed on the surface of various tumor cells, where it binds to the PD-1 receptor on T cells to suppress the immune response, thus facilitating tumor immune escape. The TGF-beta (transforming growth factor beta) gene family, on the other hand, includes multifunctional cytokines that play crucial roles in regulating cellular processes, including cell growth, differentiation, apoptosis, and homeostasis. Both PD-L1 and TGF-beta are pivotal in immune regulation and tumor progression; their interaction often contributes to the immunosuppressive tumor microenvironment. While PD-L1 directly inhibits T-cell function, TGF-beta signaling can modulate immune responses and enhance PD-L1 expression, creating a synergistic effect that leads to tumor immune evasion and progression.
仅用于科研。不用于诊断过程。未经明确授权不得转售。